Literature DB >> 28063940

Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.

Adele Romano1, Gaetano Serviddio2, Silvio Calcagnini1, Rosanna Villani2, Anna Maria Giudetti3, Tommaso Cassano4, Silvana Gaetani1.   

Abstract

4-hydroxy-2-nonenal (HNE) is considered to be a strong marker of oxidative stress; the interaction between HNE and cellular proteins leads to the formation of HNE-protein adducts able to alter cellular homeostasis and cause the development of a pathological state. By virtue of its high lipid concentration, oxygen utilization, and the presence of metal ions participating to redox reactions, the brain is highly susceptible to the formation of free radicals and HNE-related compounds. A variety of neuropsychiatric disorders have been associated with elevations of HNE concentration. For example, increased levels of HNE were found in the cortex of bipolar and schizophrenic patients, while HNE plasma concentrations resulted high in patients with major depression. On the same line, high brain concentrations of HNE were found associated with Huntington's inclusions. The incidence of high HNE levels is relevant also in the brain and cerebrospinal fluid of patients suffering from Parkinson's disease. Intriguingly, in this case the increase of HNE was associated with an accumulation of iron in the substantia nigra, a brain region highly affected by the pathology. In the present review we recapitulate the findings supporting the role of HNE in the pathogenesis of different neuropsychiatric disorders to highlight the pathogenic mechanisms ascribed to HNE accumulation. The aim of this review is to offer novel perspectives both for the understanding of etiopathogenetic mechanisms that remain still unclear and for the identification of new useful biological markers. We conclude suggesting that targeting HNE-driven cellular processes may represent a new more efficacious therapeutical intervention.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-hydroxy-2-nonenal; Huntington's disease; Parkinson's disease; bipolar disorders; depression; neuropsychiatric disorders; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28063940     DOI: 10.1016/j.freeradbiomed.2016.12.046

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  18 in total

1.  Blueberry Supplementation Mitigates Altered Brain Plasticity and Behavior after Traumatic Brain Injury in Rats.

Authors:  Gokul Krishna; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Mol Nutr Food Res       Date:  2019-05-29       Impact factor: 5.914

Review 2.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

Review 3.  Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death.

Authors:  V E Kagan; Y Y Tyurina; W Y Sun; I I Vlasova; H Dar; V A Tyurin; A A Amoscato; R Mallampalli; P C A van der Wel; R R He; A A Shvedova; D I Gabrilovich; H Bayir
Journal:  Free Radic Biol Med       Date:  2019-12-25       Impact factor: 7.376

Review 4.  Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.

Authors:  Tapan Behl; Dapinder Kaur; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Gokhan Zengin; Felicia Liana Andronie-Cioara; Mirela Marioara Toma; Simona Bungau; Adrian Gheorghe Bumbu
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

5.  Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse.

Authors:  T Seredenina; S Sorce; F R Herrmann; X-J Ma Mulone; O Plastre; A Aguzzi; V Jaquet; K-H Krause
Journal:  Transl Psychiatry       Date:  2017-08-15       Impact factor: 6.222

Review 6.  Short overview on metabolomic approach and redox changes in psychiatric disorders.

Authors:  Gordana Nedic Erjavec; Marcela Konjevod; Matea Nikolac Perkovic; Dubravka Svob Strac; Lucija Tudor; Coral Barbas; Tilman Grune; Neven Zarkovic; Nela Pivac
Journal:  Redox Biol       Date:  2017-09-06       Impact factor: 11.799

Review 7.  Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues.

Authors:  Cristina Anna Gallelli; Silvio Calcagnini; Adele Romano; Justyna Barbara Koczwara; Marialuisa de Ceglia; Donatella Dante; Rosanna Villani; Anna Maria Giudetti; Tommaso Cassano; Silvana Gaetani
Journal:  Antioxidants (Basel)       Date:  2018-07-18

Review 8.  Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia.

Authors:  Amira Bryll; Justyna Skrzypek; Wirginia Krzyściak; Maja Szelągowska; Natalia Śmierciak; Tamas Kozicz; Tadeusz Popiela
Journal:  Biomolecules       Date:  2020-03-02

Review 9.  Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.

Authors:  G Morris; A J Walker; M Berk; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2017-10-19       Impact factor: 5.590

Review 10.  From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases.

Authors:  Tommaso Cassano; Rosanna Villani; Lorenzo Pace; Antonio Carbone; Vidyasagar Naik Bukke; Stanislaw Orkisz; Carlo Avolio; Gaetano Serviddio
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.